MAGE A1 (MZ2E/838), 0.2mg/mL

Catalog number BNUB0838-100

Price for BNUB0838-100

Size / count 1x 100 µL

About this product

Recognizes a protein of 42-46 kDa, identified as MAGE-1. This MAb does not cross-react with other members of MAGE-family. Human malignant neoplasms carry rejection antigens that are recognized by the patients' autologous, tumor directed and specific, cytolytic, CD8 T lymphocyte clones (CTL) . The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs) . Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNUB0838-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: MZ2 E, cancer/testis antigen 1.1, CT1.1, MAGE1A, MAGEA1, Melanoma antigen family A 1, Melanoma associated antigen 1, Melanoma associated antigen MZ2 E
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: MAGEA1
Gene ID: 4100
NCBI Gene ID: 72879
UniProt: P43355
Swiss Prot: P43355
Host: Mouse
Species Reactivity: Human
Reactivity: MAGE-A1
Immunogen: Recombinant human MAGEA1 protein
Target Antigen: MAGE-A1
Clonality: Monoclonal
Clone: MZ2E/838
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Cancer
Positive Control: Melanoma cell lines. Melanomas, gliomas, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, and renal cell carcinomas.
Stability: 2 years
Concentration: 0.2 mg/mL
Buffer: PBS, 0.05% BSA, 0.05% azide
Molecular Weight: 42-46 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate: Purified, with BSA

Frequently Asked Questions

What is the catalog number for MAGE A1 (MZ2E/838), 0.2mg/mL?

The catalog number for MAGE A1 (MZ2E/838), 0.2mg/mL is BNUB0838-100.

What sizes are available for MAGE A1 (MZ2E/838), 0.2mg/mL?

MAGE A1 (MZ2E/838), 0.2mg/mL is available in the following size(s): 1x 100 µL.

Is MAGE A1 (MZ2E/838), 0.2mg/mL in stock?

MAGE A1 (MZ2E/838), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures MAGE A1 (MZ2E/838), 0.2mg/mL?

MAGE A1 (MZ2E/838), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for MAGE A1 (MZ2E/838), 0.2mg/mL?

Estimated delivery time for MAGE A1 (MZ2E/838), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for MAGE A1 (MZ2E/838), 0.2mg/mL?

The safety data sheet for MAGE A1 (MZ2E/838), 0.2mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is MAGE A1 (MZ2E/838), 0.2mg/mL used for?

How long will it take to receive this product if it’s custom made?

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

What is the recommended dilution for this antibody?

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

What is the recommended storage temperature after reconstitution?

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.